Disease-modifying therapies should be stopped in NMOSD patients in remission – Yes
Author(s) -
Shosha Eslam
Publication year - 2019
Publication title -
multiple sclerosis journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.729
H-Index - 131
eISSN - 1477-0970
pISSN - 1352-4585
DOI - 10.1177/1352458519829694
Subject(s) - multiple sclerosis , medicine , disease , relapsing remitting , complete remission , immunology , chemotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom